Long-term survival benefit of male and multimorbid COVID-19 patients with 5-day remdesivir treatment.
Polivka L, Gajdacsi J, Fazekas L, Sebok S, Barczi E, Hidvegi E, Sutto Z, Dinya E, Maurovich-Horvat P, Szabo AJ, Merkely B, Müller V.
Polivka L, et al. Among authors: sebok s.
J Glob Health. 2022 Aug 31;12:05031. doi: 10.7189/jogh.12.05031.
J Glob Health. 2022.
PMID: 36040909
Free PMC article.